ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Basic Mechanisms of Meditation and Cardiovascular Disease in Older Blacks

This study has been completed.

Sponsored by: National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by: National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier: NCT00010530
  Purpose

The purpose of this study is to evaluate the effects of meditation on older African Americans with documented cardiovascular disease (CVD).


Condition Intervention Phase
Cardiovascular Diseases
Procedure: Meditation
Phase I

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Single Blind
Official Title:   Basic Mechanisms of Meditation and Cardiovascular Disease in Older Blacks

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Study Start Date:   September 1999
Study Completion Date:   July 2006

Detailed Description:

Cardiovascular disease (CVD) is the leading cause of death and disability in older African Americans, and accounts for 40% of the disproportionate risk for mortality observed in African Americans compared to white Americans. The majority of CVD patients experience acute cardiac events, many sudden and unexpected, despite conventional treatment of their disease and associated traditional risk factors. The pathophysiologic basis of these cardiac events is not fully established, but substantial evidence indicates that psychosocial stress and the sympathetic nervous system have adverse effects on both vasomotor function and long-term autonomic balance. Recent advances in the understanding of the pathophysiology of acute cardiac events-specifically, the roles that arterial vasomotor dysfunction and sympathetic nervous system imbalance play in the pathophysiology of such acute events-provide a platform for a new mechanistic investigation of the interplay of psychosocial and environmental stress and CVD. Preliminary evidence demonstrating elevated peripheral vasoconstriction due to stress-mediated sympathetic nervous system response in African Americans further suggests that these mechanisms are particularly relevant in this group.

  Eligibility
Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • African-American (self-identified)
  • Local residence
  • Able to participate
  • Coronary artery disease by MI, CABG, PTCA (>3 months prior), or angiography
  • Consent and referring MD approval
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00010530

Locations
United States, California
Charles R. Drew University of Medicine and Science    
      Los Angeles, California, United States
United States, Iowa
Maharishi University of Management Center for Health and Aging Studies    
      Fairfield, Iowa, United States, 52557

Sponsors and Collaborators

Investigators
Principal Investigator:     Robert H. Schneider, MD     Center for Health and Aging Studies    
  More Information


Study ID Numbers:   P50 AT000082-01P1, P50AT000082-01, P50AT000082-02
First Received:   February 2, 2001
Last Updated:   November 6, 2007
ClinicalTrials.gov Identifier:   NCT00010530
Health Authority:   United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):
CVD  

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 07, 2008




Links to all studies - primarily for crawlers